Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Cambridge Cancer Research UK |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00758173 |
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This study is looking at genetic susceptibility and the interactions between genes and the environment in patients with prostate cancer.
Condition | Intervention |
---|---|
Prostate Cancer |
Genetic: polymorphism analysis Other: laboratory biomarker analysis Other: questionnaire administration |
Study Type: | Observational |
Official Title: | A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Prostate Cancer in East Anglia, Trent and West Midlands |
Estimated Enrollment: | 2000 |
Study Start Date: | February 2008 |
OBJECTIVES:
OUTLINE: This is a multicenter study.
Patients complete a detailed epidemiological questionnaire, including information on education, occupation, smoking habits, alcohol consumption, height, weight, family history of cancer, and past medical history.
Blood samples are collected from patients. DNA is extracted from these blood samples and from samples collected from cancer-free control participants in MREC-SEARCH-CONTROL as well as from additional controls through the European Prospective Investigation of Cancer (EPIC) study (a population based study of diet and health based in Norfolk, East Anglia). DNA samples are analyzed for polymorphisms of low penetrance cancer susceptibility genes.
In addition to the prostate cancer patients recruited for this study, patients with breast, ovarian, endometrial, colorectal, bladder, kidney, pancreatic, brain and esophageal cancer, malignant melanoma, and lymphoma cancer are recruited in the following related clinical trials: MREC-SEARCH-BREAST, MREC-SEARCH-OVARIAN, MREC-SEARCH-ENDOMETRIAL, MREC-SEARCH-COLORECTAL, and MREC-SEARCH-CANCER.
Ages Eligible for Study: | 18 Years to 74 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Kingdom:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United Kingdom, England | |
University of Cambridge Cancer Research UK | Recruiting |
Cambridge, England, United Kingdom, CB1 8RN | |
Contact: Contact Person 44-122-374-0166 paul.pharoah@srl.cam.ac.uk |
Study Chair: | Paul Pharoah, MD | University of Cambridge Cancer Research UK |
Study ID Numbers: | CDR0000589199, MREC-SEARCH-PROSTATE |
Study First Received: | September 22, 2008 |
Last Updated: | February 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00758173 History of Changes |
Health Authority: | Unspecified |
prostate cancer |
Prostatic Diseases Genital Neoplasms, Male Disease Susceptibility Urogenital Neoplasms |
Genetic Predisposition to Disease Genital Diseases, Male Prostatic Neoplasms |
Neoplasms Neoplasms by Site Prostatic Diseases Genital Neoplasms, Male |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |